Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis

There are currently several recommended drug regimens for uncomplicated falciparum malaria in Africa. Each has different properties that determine its impact on disease burden. Two major antimalarial policy options are artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DHA–PQP). Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Okell, Lucy C., Cairns, Matthew, Griffin, Jamie T., Ferguson, Neil M., Tarning, Joel, Jagoe, George, Hugo, Pierre, Baker, Mark, D’Alessandro, Umberto, Bousema, Teun, Ubben, David, Ghani, Azra C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263185/
https://www.ncbi.nlm.nih.gov/pubmed/25425081
http://dx.doi.org/10.1038/ncomms6606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263185/
https://www.ncbi.nlm.nih.gov/pubmed/25425081
http://dx.doi.org/10.1038/ncomms6606

Ejemplares similares